Evidence map›Paper›PMID 35643079›Full record

ArticleCell host & microbe2022

Impact of a 7-day homogeneous diet on interpersonal variation in human gut microbiomes and metabolomes.

Leah Guthrie, Sean Paul Spencer, Dalia Perelman, Will Van Treuren, Shuo Han, Feiqiao Brian Yu, Erica D Sonnenburg, Michael A Fischbach, Timothy W Meyer, Justin L Sonnenburg

Open access · greenAbstract read
In one paragraph

Article in Cell host & microbe, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Microbiota-gut-kidney axis in health and renal disease.International journal of biological sciences · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Gut Microbiota Shifts with Lifetime Duration of Oral Contraception Use.bioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. High-Diversity Plant-Based Diet and Gut Microbiome, Plasma Metabolome, and Symptoms in Adults with CKD.Clinical journal of the American Society of Nephrology : CJASN · 2025
    Article
  19. Review
  20. Quantifying compositional variability in microbial communities with FAVA.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Leah GuthrieDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Sean Paul SpencerDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Dalia PerelmanStanford Prevention Research Center, Department of Medicine, Stanford School of Medicine, Stanford, CA 94305, USA.
Will Van TreurenDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Shuo HanDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Feiqiao Brian YuChan-Zuckerburg Biohub, San Francisco, CA 94158, USA.
Erica D SonnenburgDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Michael A FischbachDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; ChEM-H, Stanford University, Stanford, CA 94305, USA; Chan-Zuckerburg Biohub, San Francisco, CA 94158, USA; Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.
Timothy W MeyerDepartment of Medicine, VA Palo Alto Health Care System, Palo Alto, CA 94304, USA.
Justin L SonnenburgDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA; Chan-Zuckerburg Biohub, San Francisco, CA 94158, USA; Center for Human Microbiome Studies, Stanford, CA 94305, USA. Electronic address: jsonnenburg@stanford.edu.
Stanford University · USChan Zuckerberg Initiative (United States) · USStanford Medicine · USVA Palo Alto Health Care System · US

Funding

WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Jennifer Lynn Powers Carson · 2013 to 2026
$27.1M
Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5M
Project 3: Microbiota generated aryl sulfates and secondary bile acids in cardiometabolic diseaseP01HL147823 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI Joseph DiDonato · 2019 to 2026
$17.0M
MOLECULAR BASIS OF HOST-PARASITE INTERACTIONT32AI007328 · NIAID · STANFORD UNIVERSITY · PI JUSTIN L SONNENBURG · 1987 to 2026
$11.9M
Dietary and Microbial Reprogramming of Intestinal Microbiota-Produced MetabolitesR01DK101674 · NIDDK · STANFORD UNIVERSITY · PI FISCHBACH, MICHAEL ANDREW, MEYER, TIMOTHY W · 2014 to 2024
$6.5M
TRAINING GRANT IN ACADEMIC GASTROENTEROLOGYT32DK007056 · NIDDK · STANFORD UNIVERSITY · PI Natalie J. Torok · 1986 to 2026
$6.5M
Impact of Diet on Intestinal Microbiota-Host DynamicsR01DK085025 · NIDDK · STANFORD UNIVERSITY · PI JUSTIN L SONNENBURG · 2010 to 2026
$6.4M
Impact of gut microbiota-derived molecules on mammalian host health and longevityF32AG062119 · NIA · STANFORD UNIVERSITY · PI HAN, SHUO · 2019 to 2021
$202k
NHLBI NIH HHS P01 HL147823NIAID NIH HHS T32 AI007328NIA NIH HHS F32 AG062119NIDDK NIH HHS P30 DK020579NIDDK NIH HHS R01 DK085025NIDDK NIH HHS R01 DK101674NIDDK NIH HHS T32 DK007056
6 · The paper itself

Abstract

Gut microbiota metabolism of dietary compounds generates a vast array of microbiome-dependent metabolites (MDMs), which are highly variable between individuals. The uremic MDMs (uMDMs) phenylacetylglutamine (PAG), p-cresol sulfate (PCS), and indoxyl sulfate (IS) accumulate during renal failure and are associated with poor outcomes. Targeted dietary interventions may reduce toxic MDM generation; however, it is unclear if inter-individual differences in diet or gut microbiome dominantly contribute to MDM variance. Here, we use a 7-day homogeneous average American diet to standardize dietary precursor availability in 21 healthy individuals. During dietary homogeneity, the coefficient of variation in PAG, PCS, and IS (primary outcome) did not decrease, nor did inter-individual variation in most identified metabolites; other microbiome metrics showed no or modest responses to the intervention. Host identity and age are dominant contributors to variability in MDMs. These results highlight the potential need to pair dietary modification with microbial therapies to control MDM profiles.

Indexed as

Gastrointestinal MicrobiomeMicrobiotaDietHumansIndicanMetabolomeIndicandietary interventionmicrobiomemicrobiome-dependent metabolitesprecision medicineuremic solutes

Identifiers

PMID35643079
PMCPMC9296065
OpenAlexW4281702972

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.